S. Nandakumar

Statistical application in Image Processing by Integrating C and SAS

V. Venkataraman, S. Nandakumar, 2019 .

Statistical Procedures for Bioequivalence Analysis

S. Nandakumar, 2009 .

Universal: An Allogeneic First-in-Human Study of the Anti-Bcma ALLO-715 and the Anti-CD52 ALLO-647 in Relapsed/Refractory Multiple Myeloma

P. Hari, M. Liedtke, O. Oluwole, 2020 .

A first-in-human phase 1 trial of NX-2127, a first-in-class oral BTK degrader with IMiD-like activity, in patients with relapsed and refractory B-cell malignancies.

I. Flinn, A. Wiestner, S. O'brien, 2022, Journal of Clinical Oncology.

Talapro-2: A 2-part, placebo-controlled phase 3 study of talazoparib (TALA) with background enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage repair deficiencies.

J. Carles, N. Agarwal, A. Fay, 2018 .

Comparison of Sample Size Requirements of Randomized and Historically Controlled Trials Based on Calibrated Error Rates

Srinand Nandakumar, Steven M. Snapinn, S. Snapinn, 2021, Statistics in Biopharmaceutical Research.